Wednesday, Aug 05, 2020 | Last Update : 01:48 AM IST

133rd Day Of Lockdown

Maharashtra45795629935616142 Tamil Nadu2682852087844349 Andhra Pradesh176333956251604 Karnataka145830692722704 Delhi1391561252264033 Uttar Pradesh100310572711817 West Bengal80984568841785 Telangana6894649675563 Gujarat65704485612529 Bihar6203140760349 Assam4816233429115 Rajasthan4667932832732 Haryana3779631226448 Odisha3768124483258 Madhya Pradesh3508225414912 Kerala279561629988 Jammu and Kashmir2239614856417 Punjab1901512491462 Jharkhand140705199129 Chhatisgarh10109761369 Uttarakhand8008484795 Goa7075511460 Tripura5520367528 Puducherry4147253758 Manipur301818147 Himachal Pradesh2879171013 Nagaland24056594 Arunachal Pradesh179011053 Chandigarh120671520 Meghalaya9173305 Sikkim7832971 Mizoram5022820
  India   All India  13 Mar 2017  Diabetes raises risk of cancer death in Asians

Diabetes raises risk of cancer death in Asians

THE ASIAN AGE. | TEENA THACKER
Published : Mar 13, 2017, 12:58 am IST
Updated : Mar 13, 2017, 6:06 am IST

Diabetes was associated with a 26 per cent increased risk of death from any cancer in Asians.

The number of cancers of the gallbladder and bile ducts in Asia were comparable to those in the West.
 The number of cancers of the gallbladder and bile ducts in Asia were comparable to those in the West.

New Delhi: Public health experts at New York University’s School of Medicine have found that diabetes increased the risk of cancer death in Asians. Researchers also revealed that Asians with Type 2 diabetes are more likely to be diagnosed with rarer cancers than Westerners, including cancers of the liver, thyroid and kidney, which was double the risk compared to non-diabetics in Asia.

According to the study, published in medical journal Diabetologia, “Diabetes was associated with a 26 per cent increased risk of death from any cancer in Asians. The pattern of associations with specific cancers suggests the need for better control (prevention, detection, management) of the growing epidemic of diabetes (as well as obesity) in order to reduce cancer mortality,” it said.

 

Stating that the study is an eye-opener for physicians in India, Dr Anoop Misra, National Diabetes Obesity & Cholesterol Foundation president recommended using metformin, a frontline diabetes drug, for its anti-cancer property. “Cancers as result of diabetes is often not known, or being clearly forgotten by most Indian physicians. Any unusual weight loss or any other symptoms in patient of diabetes should be investigated aggressively for cancer. Interestingly, metformin, a frontline diabetes drug, has anti-cancer property, and should be used in maximised dose,” he said.

The study aimed to evaluate the association between Type 2 diabetes and the risk of death from any cancer and specific cancers in East and South Asians found that there was more than two-and-a-half times increased risk of cancer of the endometrium and a 1.7 times higher risk of breast cancer among diabetic Asians compared to those who were not diabetic. The number of cancers of the gallbladder and bile ducts in Asia were comparable to those in the West.

 

The study drew on an analysis from about 770,000 people with Type 2 diabetes throughout East and South Asia. Diabetics were followed for an average of 13 years to see if they developed cancer and what types. During that time, more than 37,300 cancer deaths were identified.

Study’s lead author Yu Chen, an epidemiology professor at the NYU School of Medicine’s Department of Population Health, said Asians with Type 2 diabetes are more likely to be diagnosed with rarer cancers than Westerners. There may be several mechanisms at work, but data suggests that insulin may in some way stimulate the growth of cancer.

According to her, Type 2 diabetes should be added to the list of cancer risk factors, along with diet and cigarette smoking. “Cancer prevention needs to take into account for diabetes,  which may reduce the risk of diabetes and also cancer,” she added.

 

Tags: diabetes, cancer, cholesterol
Location: India, Delhi, New Delhi